Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of NF-&kgr;B inhibition in combination therapy for cancer

Use of NF-&kgr;B inhibition in combination therapy for cancer

US Patent 6831057 · Granted Dec 14, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of the Wnt/beta-catenin pathway2025
Inhibitors of the WNT/beta-catenin pathway2023
Methods of treating muscular wasting diseases using NF-KB activation inhibitors2015
Methods of treating muscular wasting diseases using NF-κB activation inhibitors2013
Use of NF-κB inhibition in combination therapy for cancer2010
Use of NF-κB inhibition in combination therapy for cancer2010
Use of NF-κB inhibition in combination therapy for cancer2010
Use of NF-κB inhibition in combination therapy for cancer2010
Use NF-κB inhibition in combination therapy for cancer2010
Use NF-κB inhibition in combination therapy for cancer2010
Use NF-κB inhibition in combination therapy for cancer2010
Use NF-κB inhibition in combination therapy for cancer2010